MYC and cancer: However, in virtually all cancers this tight quantitative and temporal regulation is disrupted by various mechanisms, such as amplification of the c-myc gene (hereafter Myc) or its regulatory enhancers, chromosomal translocation, stabilising mutation or, most commonly, relentless induction by “upstream” oncogenic drivers11.